« Older Entries
Newer Entries »
argenx announces results of Annual General Meeting 2017
Wednesday, April 26th, 2017
Breda, the Netherlands / Ghent, Belgium, April 26, 2017 - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for [...]
Kuros announces CEO succession
Thursday, April 13th, 2017
Commercialization veteran and life science executive Dr. Ivan Cohen-Tanugi named Chief Executive Officer of Kuros
Didier Cowling will serve as President on the Executive Committee and remain on the Board of [...]
15th BioCapital Europe
Tuesday, April 11th, 2017
March 15, 2017 – The 15th BioCapital Europe Conference took place at the prestigious The Grand Hotel (Sofitel) in Amsterdam. The conference is organized by LSP and this year attracted a record breaking attendance. D [...]
Marco Groot over LSP in het FD
Monday, April 10th, 2017
Amsterdam, April 11, 2017
Marco Groot over LSP in het FD
Lees de gehele column: Een absoluut beter resultaat
Amsterdam, July 11, 2017:
Marco Groot blikt in het FD terug op zijn eerdere positiev [...]
LSP’s portfolio company Neuravi acquired by Codman Neuro
Monday, April 10th, 2017
Amsterdam, the Netherlands, April 10, 2017 – LSP (Life Sciences Partners), a leading European investor in health care, announces the acquisition of its portfolio company Neuravi Limited by Codman Neuro, part of the [...]
Last Patient Last Visit (LPLV) reached in the SAPHIR Study
Friday, April 7th, 2017
Last Patient Last Visit (LPLV) reached in the SAPHIR Study, a Phase 2 trial with the Glutaminyl Cyclase (QC) inhibitor PQ912 in early Alzheimer's Disease (AD)
HALLE (SAALE), Germany, 07 April 2017 - Pro [...]
« Older Entries
Newer Entries »
Follow us
